Page 6 - Asthma Control News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  an anti-inflammatory reliever in mild asthma   therapy approved in China for mild, moderate and severe asthma   AstraZeneca's Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to achieve asthma control in patients with mild asthma aged 12 years and older.   The approval by the National Medical Products Administration (NMPA) was based on positive results from the SYGMA 1 and SYGMA 2 Phase III trials, published in The...

Dec 23, 2020 However, it may result in higher health care use Sensor-based inhaler monitoring with clinical feedback may improve asthma symptom control in children, as well as caregiver quality of life, according to a randomized trial evaluating a sensor-based electronic monitoring system. Such a system would work well in racially and economically diverse pediatric populations, researchers found. However, this intervention was also associated with higher health care usage, suggesting that further “platform refinement” is warranted. The study, from Ruchi S. Gupta, MD, MPH, Feinberg School ...